ARTICLE | Company News
Grifols sales and marketing update
December 6, 2010 8:00 AM UTC
Grifols launched Flebogamma 10% dual inactivated filtered IV immunoglobulin ( IVIG) in the U.S. as replacement therapy in patients with primary immunodeficiency diseases. The price of the product was ...